More Ultrasound-Guided Percutaneous Microwave Ablation Leads to Higher Immune-Related Gene Expression and Boosts PD-1 Monoclonal Antibodies for Liver Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
More Ultrasound-Guided Percutaneous Microwave Ablation Leads to Higher Immune-Related Gene Expression and Boosts PD-1 Monoclonal Antibodies for Liver Cancer
Authors
Keywords
-
Journal
ULTRASOUND IN MEDICINE AND BIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-10-21
DOI
10.1016/j.ultrasmedbio.2023.09.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6
- (2022) Songjiang Huang et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
- (2022) Uasim Harkus et al. SEMINARS IN CANCER BIOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma
- (2021) Won‐Mook Choi et al. LIVER INTERNATIONAL
- Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer
- (2021) Wenbin Zhou et al. Journal for ImmunoTherapy of Cancer
- Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B
- (2021) Yanan Gao et al. JOURNAL OF HEPATOLOGY
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
- (2021) Zhenggang Ren et al. LANCET ONCOLOGY
- Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Yunpeng Yang et al. LANCET ONCOLOGY
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
- (2020) Shukui Qin et al. LANCET ONCOLOGY
- DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
- (2020) Linbin Yang et al. NATURE
- Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
- (2020) Lin Shen et al. Journal for ImmunoTherapy of Cancer
- Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
- (2020) Katharina Leuchte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
- (2020) Ning Lyu et al. Frontiers in Oncology
- Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis
- (2019) Thomas Yau et al. JOURNAL OF HEPATOLOGY
- Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
- (2019) Chen Lu et al. Molecular Cancer
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumorigenesis, diagnosis, and therapeutic potential of exosomes in liver cancer
- (2019) Hongbo Wang et al. Journal of Hematology & Oncology
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: A pre-clinical study in a murine model
- (2018) J. Zhu et al. Diagnostic and Interventional Imaging
- Tremelimumab in combination with microwave ablation in patients with refractory biliary tract cancer
- (2018) Changqing Xie et al. HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer
- (2017) Li Li et al. Journal of Translational Medicine
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Immuno-thermal ablations – boosting the anticancer immune response
- (2017) Ryan Slovak et al. Journal for ImmunoTherapy of Cancer
- Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
- (2016) Antonio Facciorusso et al. INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started